Anti-epileptic drugs
Showing 9976 - 10000 of >10,000
Myeloid Hematological Malignancies Trial in Houston (Busulfan, Cyclophosphamide, Fludarabine)
Completed
- Myeloid Hematological Malignancies
- Busulfan
- +3 more
-
Houston, TexasTexas Children's Hospital
May 13, 2022
Calculi, Urinary, Dietary Supplements, Urine Specimen Collection Trial in Shanghai (Giving subjects different phosphorus diets
Active, not recruiting
- Calculi, Urinary
- +2 more
- Giving subjects different phosphorus diets at different stages of the trial
-
Shanghai, Shanghai, ChinaShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Ton
Nov 17, 2022
Hepatitis C, Diagnostic Self Evaluation Trial in Nationally (OraQuick® HCV Self-Test, First Response® HCV Self-Test)
Recruiting
- Hepatitis C
- Diagnostic Self Evaluation
- OraQuick® HCV Self-Test
- First Response® HCV Self-Test
-
Nationally, MalaysiaJom test platform
Feb 10, 2022
Multiple Primary Lung Cancers Trial in China (furmonertinib, Placebo)
Recruiting
- Multiple Primary Lung Cancers
- furmonertinib
- Placebo
-
Fuzhou, Fujian, China
- +5 more
Oct 4, 2021
Coronavirus Infection, Diabetes Trial in Corvallis (Pioglitazone)
Completed
- Coronavirus Infection
- Diabetes
-
Corvallis, OregonGood Samaritan Hospital Corvallis
Dec 2, 2020
Insulin Resistance, Metabolic Syndrome Trial in Granada (Functional olive oil, Olive oil)
Completed
- Insulin Resistance
- Metabolic Syndrome
- Functional olive oil
- Olive oil
-
Granada, SpainFaculty of Health Sciences (University of Granada)
Sep 10, 2021
HER2-positive Breast Cancer Trial in Beijing (GB221,2 mg/kg, GB221,6 mg/kg, Herceptin,6 mg/kg)
Recruiting
- HER2-positive Breast Cancer
- GB221,2 mg/kg
- +5 more
-
Beijing, Beijing, ChinaAffiliated Hospital of Academy of Military Medical Sciences
Mar 2, 2021
Sarcoma,Soft Tissue Trial in Spain (Selinexor 20 MG, Gemcitabine)
Recruiting
- Sarcoma,Soft Tissue
- Selinexor 20 MG
- Gemcitabine
-
Tenerife, Canarias, Spain
- +10 more
Oct 27, 2023
Pneumonia, Pneumocystis Carinii, HIV Trial in Stony Brook (Pentamidine isethionate, Zidovudine)
Completed
- Pneumonia, Pneumocystis Carinii
- HIV Infections
- Pentamidine isethionate
- Zidovudine
-
Stony Brook, New YorkSUNY - Stony Brook
Oct 28, 2021
Open-angle Glaucoma, Diabetic Retinopathy Trial in New York (GlaucoHealth, GlaucoSelect, Placebo)
Terminated
- Open-angle Glaucoma
- Diabetic Retinopathy
- GlaucoHealth
- +2 more
-
New York, New YorkNew York Eye and Ear Infirmary of Mount Sinai
Mar 15, 2021
Liver Metastases, Primary Liver Cancers Trial in Boston (administration of rRp450 into the hepatic artery)
Recruiting
- Liver Metastases
- Primary Liver Cancers
- administration of rRp450 into the hepatic artery
-
Boston, MassachusettsMassachusetts General Hospital
Nov 23, 2021
Multiple Myeloma Trial in Little Rock (Velcade, Melphalan, Thalidomide)
Active, not recruiting
- Multiple Myeloma
- Velcade
- +7 more
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Sep 7, 2021
Brain and CNS Tumors, Solid Tumor Trial in United States (temozolomide, thalidomide, radiation therapy)
Completed
- Brain and Central Nervous System Tumors
- Unspecified Adult Solid Tumor, Protocol Specific
- temozolomide
- +2 more
-
Decatur, Illinois
- +4 more
Sep 7, 2021
Breast Cancer Trial in France, Monaco (drug, other, radiation)
Recruiting
- Breast Cancer
- EXPERIMENTAL ARM
- +2 more
-
Mougins, Alpes-Maritimes, France
- +6 more
Jan 7, 2022
CYP3A Inhibitor, Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma Trial in Heidelberg (Cobicistat Oral Tablet)
Not yet recruiting
- CYP3A Inhibitor
- Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma
- Cobicistat Oral Tablet
-
Heidelberg, BW, GermanyUniversity Hospital Heidelberg
Aug 10, 2022
Sarcoma,Soft Tissue Trial in France (Pre-operative radiotherapy followed by 2 cycles of atezolizumab then surgery, 2 cycles of
Recruiting
- Sarcoma,Soft Tissue
- Pre-operative radiotherapy followed by 2 cycles of atezolizumab then surgery
- +2 more
-
Bordeaux, France
- +4 more
Mar 28, 2022
Postoperative Vomiting, Postoperative Nausea, Postoperative Delirium Trial in Istanbul (Group N; neostigmine+atropine, GROUP S;
Active, not recruiting
- Postoperative Vomiting
- +2 more
- Group N; neostigmine+atropine
- GROUP S; decurarized with sugammadex.
-
Istanbul, Maltepe, TurkeyMarmara University
Nov 8, 2022
Prostate Cancer, Prostatectomy, Enhanced Recovery After Surgery Trial in Beijing (Routine care, ERAS management pathway)
Not yet recruiting
- Prostate Cancer
- +4 more
- Routine care
- ERAS management pathway
-
Beijing, Beijing, ChinaDepartment of Anesthesiology and Critical Care Medicine, Peking
Oct 11, 2022
Pseudomonas Aeruginosa in Cystic Fibrosis Trial in United States (TOBI® PODHALER®, TOBI®, Bethkis®)
Completed
- Pseudomonas Aeruginosa in Cystic Fibrosis
- TOBI® PODHALER®
- +3 more
-
Anchorage, Alaska
- +46 more
Mar 7, 2022
Linking Epidermal Barrier Function With Anti-Oxidant Defense
Terminated
- Atopic Dermatitis
- +3 more
-
Tucson, ArizonaUniversity of Arizona - Banner University Medicine Dermatology
Jun 1, 2021
Refractory Metastatic Colorectal Cancer, pMMR, MSS Trial in Hangzhou (Bevacizumab, Tripleitriumab)
Unknown status
- Refractory Metastatic Colorectal Cancer
- +2 more
-
Hangzhou, Zhejiang, Chinathe Second Affiliated Hospital of Medical College of Zhejiang Un
Sep 15, 2020
Stage III Distal Bile Duct Cancer AJCC v8, Stage III Gallbladder Cancer AJCC v8, Stage III Intrahepatic Cholangiocarcinoma AJCC
Active, not recruiting
- Stage III Distal Bile Duct Cancer AJCC v8
- +16 more
- Cisplatin
- +2 more
-
Anchorage, Alaska
- +691 more
Oct 8, 2021
Cutaneous Warts Trial in Leiden (Cypep-1)
Completed
- Cutaneous Warts
-
Leiden, Zuid-Holland, NetherlandsCentre for Human Drug Research
Aug 2, 2021